Finally, GSEA indicated that after PAQR3 knockdown, growth- and tumor-related pathways exhibited an upregulation trend, providing new insights and a foundation for understanding the tumor-suppressive role of PAQR3 in colon cancer (Figure 5E). Here, PAQR3 is linked to colonic neoplasm.